daniel villarreal ('lgbtq nation') reports:
Blumineck — a self-described “archer, pole dancer, and nerd” based in Leeds, England, with over 4.1 million followers on YouTube, TikTok, and Instagram — posted a viral video on Monday, directly addressing web commenters who have accused him and his wife of being transgender — both he and his wife are cisgender.
In the video, which has been viewed over 6 million times on various video platforms, the viral influencer explains how the policing of gender hurts cis and trans people alike, and he reminds viewers, “How you dress and what you do for fun don’t determine your identity.”
Blumineck normally posts videos of himself doing impressive trick shots with his bow and arrow or spinning and hanging from a stripper pole while wearing unique clothing — like high-heeled boots, harem pants, or nipple pasties over his bare chest. Other times, he will spar with his wife using different medieval weapons, like swords.
In his Monday video, entitled “Educating haters (again),” Blumineck posted screenshots of web commenters telling him to get a DNA test, calling him and his wife “two dudes,” and claiming that her name is Max (her name is Maisie) and saying she has a bigger Adam’s apple than him.
“Are we not past this?” he says at the start of his video. “I’ve been going out of my way to show that how you dress and what you do for fun don’t determine your identity. But there are still some idiots out there calling my wife a man because she happens to have some muscle. So let’s get a couple more things clear.”
He then says that, because aging women are at higher risk of weakened bones through osteoporosis, lifting weights and building muscle are the best ways to combat that risk. “Being strong is arguably far more important for the average woman than it is for the average man,” he says.
“Secondly,” he adds, “I don’t give a gnat’s fart whether you think that I or my wife are transgender because it doesn’t matter.”
“Policing people’s gender hurts everyone,” he continues. “It hurts transgender people, who, whether you like it or not, are one of the most vulnerable populations,” he adds, displaying a headline from a 2018 Williams Institute study showing that trans people are four times more likely than cisgender people to be victims of violent crime.
“It also hurts all women, whether they happen to be taller or stronger, or have short hair, or wear different makeup, or who otherwise don’t fit into society’s incredibly narrow beauty standards,” he says, displaying headlines about a cis teen girl who was forced to prove her gender in a restaurant’s women’s restroom, a cis Olympic boxer who was harassed over false claims that she’s trans, and two women tried for slander after claiming that French First Lady Brigitte Macron is trans.
good points. and we all need to stand up to those who try to bully transgender people. there's no excuse for it. i know chump and his minions live to whip up hatred but their act has gotten old and the rest of us should have gotten wiser.
'general hospital'?
molly may be the only 1 capable of seeing reality on the program. she went to work out and bumped into detective fitzgerald and then into lucas. they explained that they were living together because lucas rented the apartment but then lucy coe rented it the next day to fitzgerald and they both tried to move in the same day when they found out. so they were temporarily sharing the apartment.
fitz goes off and molly tells lucas how happy she is for him. what? the chemistry between the 2 is obvious. lucas tells her no, it's not like that. she looks at him skeptically.
fitz walks over and asks what they're talking about and molly says she realized her instructor's class was tomorrow, not today, so she was going to hop in the steam room.
on her way, she sees elizabeth instructing dante on a stretch and her eyes say there's something more there than just friendship.
danny is looking for charlotte and can't find her. then he gets worried and remembers her efforts to get drew on camera with her so that they can blackmail him into letting scout see her brother (danny). and that's what she's up to. she's at the metro court. she sees the valet take drew's car keys, she gets them, crawls into his car and pulls her jacket down to reveal black lingerie. she's set her cell phone outside the car to record her throwing her arms around drew when he gets in the car.
drew is inside the metro court talking to jordan. she says that she wants brook lynn - now that she's confessed to being the 1 who left the scene of the accident - to use the quartermaine's power to get curtis released from prison early. drew says he'll use his old contacts from when he was in congress to help on that as well.
lulu and cassadine are at the metro court as well. why? lulu heard from olivia (ned's wife) that charlotte was with danny when danny took chase's truck out for a ride (without chase's permission) and got into an accident. she thinks she should have been told - cassadine says he discussed it with jason - and she thinks charlotte and danny together is not a good idea.
ric goes to willow and tells her the wsb suspects her mother of jack's disappearance and possible murder. willow says that makes no sense and they talk more with ric asking questions and then finally when willow says she's getting her mother out of custody - ric tells her that they took nina off to a black site in switzerland. what!!! willow tells him he should have led with that. she tells him that he's on retainer and to start filing every motion he can against the wsb. she's off to the appropriations committee and she's going to bring pressure down on the wsb via her position as a member of congress.
some 1 opens drew's car door ...
we know it's not drew from charlotte's reaction to the clips at the end about monday's show. i'm guessing it's rocco.
it was a strong episode. and again, good for molly for noticing what's been apparent since fitz had his 1st scene with lucas months ago but no 1 else has noticed.
let's close with c.i.'s 'The Snapshot:"
The ticketed event at JR’s SouthPork Ranch benefited Team Nunn, a joint fundraising committee that includes Nunn’s campaign, his leadership political action committee and the National Republican Congressional Committee. Admission ranged from $26 to $3,500, with the two highest tiers including access to a VIP reception.
The complaint asks federal investigators to determine whether Hegseth used the authority or influence of his office to affect the November election and whether government resources used for his trip were properly paid for or reimbursed.
Hegseth endorsed Nunn from the stage while discussing his work leading the Pentagon.
Attorney General Todd Blanche has repeatedly participated in campaign events and spoken in partisan terms about the coming midterm elections since his confirmation last month, despite criticism that he violated a longstanding Justice Department principle of steering clear of electoral politics.
This week he waded again into those waters — twice.
Since August, Mr. Blanche has come under fire for making campaign-tinged public appearances and comments. Last month, at a rally-style event on Long Island, he praised Bruce Blakeman, the Republican candidate for governor of New York. Last week, Mr. Blanche delivered remarks at the Republican Party’s midterm convention.
On Tuesday, he stood at the White House podium and disparaged Democratic lawmakers while invoking the coming election, dismissing their concerns about artificial intelligence as “nothing but an effort to influence the midterms.”
And on Wednesday, Mr. Blanche spoke at a campaign rally for Michael Whatley, the Republican Senate candidate in North Carolina. Echoing his convention speech, he portrayed crime rates, which continued a long-term downward trend to reach new lows in 2025, as “President Trump and Vice President Vance delivering on a promise.”
Worries about the Justice Department abandoning its long-held commitment to appear apolitical in order to maintain institutional credibility may seem beside the point. Since January 2025, dozens of judges have viewed its representations with suspicion, eroding the traditional bonds of trust, known as the “presumption of regularity,” that the courts typically grant the department.
The second Trump administration has also unabashedly destroyed the post-Watergate norm of Justice Department independence from the White House in investigative decisions. Early on, Mr. Blanche’s predecessor, Pam Bondi, declared, “We are so proud to work at the directive of Donald Trump.” Last September, after Mr. Trump publicly demanded that she charge several perceived adversaries, the department pushed through short-lived indictments of two of them.
Still, Mr. Blanche is dismantling another post-Watergate principle: that Justice Department leaders stay away from partisan politicking.
Joseph Tirrell, the Justice Department’s senior ethics official until the Trump administration dismissed him in July 2025, earlier this week criticized Mr. Blanche’s participation in the Republican convention. He called the attorney general’s comments at the White House briefing “borderline” unethical, and his participation in the North Carolina rally “terrible.”
Chump has never been a good leader. He has destroyed our country's standing on the global stage. He is an idiot, a raving lunatic, who keeps talking of, for example, annexing this place or that -- Canada, Greenland, you name it. This is not normal. This is not rational. These are the remarks of a psychopath, of a Hitler storming through Europe and trying to take over countries. That's what it is. And America is loathed for his remarks and for his tariffs and for his prissy personality. Heather Digby Parton (SALON) observes of Chump:
Warren: “Was Secretary Kennedy lying when he said he would make those deals available to us?”
Warren: “Show me the receipts.”
Washington, D.C. — At a hearing of the Senate Finance Committee, U.S. Senator Elizabeth Warren (D-Mass.) questioned Chris Klomp, President Trump’s nominee to be Deputy Secretary of the Department of Health and Human Services (HHS), on President Trump’s secret deals with drug companies.
President Trump has bragged about the administration’s Most Favored Nation (MFN) agreements with pharmaceutical companies, claiming that it has reduced prescription drug prices by as much as 600%, which Senator Warren noted would “mean companies should be paying you to take their drugs.” But the deals for prices on that website have still not been released by President Trump or by Big Pharma.
In April 2026, at a hearing of the Senate Finance Committee, Senator Warren pressed HHS Secretary Robert F. Kennedy Jr. on the deals struck with pharmaceutical companies. When pressed on whether he would publicly disclose the deals, Secretary Kennedy — with Mr. Klomp sitting right behind him — confirmed, “I’m happy to make the deals available.” But Secretary Kennedy has broken this promise.
“Mr. Klomp, was Secretary Kennedy lying when he said he would make those deals available to us?” asked Senator Warren. When questioned about Kennedy’s failure to share these deals with Congress, Klomp refused to explain why the contracts have not been released.
“Show me the receipts,” said Senator Warren. “Five months ago, the Secretary promised that he would deliver those contracts. It’s been five months, and we don’t have them.”
Senator Warren noted that pharmaceutical companies that have made these agreements have represented them in earnings reports as unlikely to affect their financial outlook. Earlier this month, the biotech company Insight Corporation wrote that it does not expect its deal with the Trump administration to “have a material impact on its future financial outlook.” One analyst described Pfizer’s deal as “immaterial,” and Novartis and Roche have made the same representations about their own deals.
The senator also questioned what giveaways Big Pharma companies may have received in exchange for striking these secret deals with the Trump administration. “I want to know what was given away in these contracts,” stated Senator Warren, including whether drug companies received tariff relief, exemptions from drug pricing demonstrations in Medicare, fast-track FDA approval, and higher prices abroad instead of lower prices in the U.S.
“I want to see what the deal is, and until then, you can stop telling us it was all great for the American people, but you just refused to show us the receipts. That’s not how oversight works,” concluded Senator Warren.
Transcript: Hearings to examine the nominations of Gerard Klomp, of Utah, to be Deputy Secretary, and Ge Bai, of Virginia, to be an Assistant Secretary, both of the Department of Health and Human Services, James Gadwood, of Maryland, to be Chief Counsel for the Internal Revenue Service and an Assistant General Counsel in the Department of the Treasury, and Andrew A. De Mello, of Virginia, to be a Judge of the United States Tax Court for a term of fifteen years.
Senate Finance Committee
September 15, 2026
Senator Elizabeth Warren: Last year, President Trump and the Republicans slashed health care for millions of Americans. It caused premiums to skyrocket. Americans are now paying the price. And President Trump’s one answer is to say, “Check out the Trump RX website” and the supposedly great deals that he has made with big pharma. So I want to take a look. These deals are secret, but from what we can see, they don’t look so great. That’s why in April, when Secretary Kennedy was here, I asked him if he would make the deals available to the committee. And Mr. Klomp, since you were the Secretary’s chief counselor, you were sitting right behind him when he said, “I’m happy to make the deals available, except for proprietary information and trade secrets.” Now that was five months ago. Since then, I have sent two letters to Secretary Kennedy, asking him to make good on that commitment, but he has not kept his word.
Mr. Klomp, was Secretary Kennedy lying when he said he would make those deals available to us?
Mr. Klomp: Senator Warren, I do not believe he was lying. I believe that we need to make an important distinction between operative policy and internal deliberative materials. The principles of the deals, the frameworks, the results of them, in fact, from a pricing perspective, are fully available—
Senator Warren: I’m sorry, let me just start here. You signed a contract with each of these pharmaceutical companies, right?
Mr. Klomp: Correct.
Senator Warren: I taught contract law for 30 years. I want to see the contracts, and that is what I asked the Secretary for, and the Secretary said he would deliver those contracts. He might cross out certain proprietary information, trade secrets. I’m fine with that. I want to understand the numbers, and the only way I can do that is with the contracts. So where are the contracts?
Mr. Klomp: Senator, the numbers, for example, are freely available. You can see exactly the results of every contract on TrumpRX today.
Senator Warren: No, there are no contracts that are available that I can see who made how much money on what deal. I have your general summary, but that’s not what I asked the Secretary for, and it’s not what the Secretary promised to deliver. In fact, HHS continues to keep every one of these deals secret at the same time the president brags that he has lowered prices by 600%, which would mean, of course, that companies are paying you to take the drugs. Aside from that outlandish claim, if these deals were in fact so good, so profitable for the United States, then I would expect that they would lower Big Pharma’s profits. But what executives are telling their investors is not so much. Earlier this month, the biotech company Insight Corporation wrote in its earnings report that it does not expect its deal with the Trump administration to “have a material impact on its future financial outlook.” An analyst described Pfizer’s deal as “immaterial.” And Novartis and Roche have said the same thing about their own deals.
Mr. Klomp, you and Secretary Kennedy are keeping these pharma deals secret, the companies are saying they are immaterial, and you still want the American people to believe that they are somehow a really great deal for our country? That we’re getting great prices here?
Mr. Klomp: Senator Warren, billions of dollars have already been saved in out-of-pocket transactions through GLP-1s—
Senator Warren: Then show me the receipts.
Mr. Klomp: —infertility, or otherwise.
Senator Warren: Show me the receipts. Why are you hiding these contracts?
Mr. Klomp: We’re not hiding anything. In fact, in the Inflation Reduction Act, you inserted the same provisions as Congress, recognizing that if trade secrets, proprietary information were to be shared, that would compromise the government’s ability to negotiate anything.
Senator Warren: I’m sorry, let me just stop you right there. You say you’re not hiding anything. Five months ago, the Secretary promised that he would deliver those contracts. It’s been five months, and we don’t have them. I would regard that as hidden. So where are the contracts that are so great and going to show how much money you have saved?
Mr. Klomp: Senator Warren, I know that you care deeply about lowering prescription drug prices for Americans.
Senator Warren: I do.
Mr. Klomp: I agree with you strongly on this point. I know that you wouldn’t want to do something that would compromise the U.S. government’s ability to continue negotiating, which we are actively negotiating with other countries—
Senator Warren: No, these are contracts that are already written that I want to see.
Mr. Klomp: But our negotiations—
Senator Warren: And that Kennedy sat there, said he would do. You sat right behind him. Everybody nodded, and nobody did it. Look, I want to know what was given away in these contracts. I want to see whether these drug companies got tariff relief. Did they get exemptions from drug pricing demonstrations in Medicare? Did they get fast-track FDA approval? Did they get the U.S. government not pushing for lower prices here but for higher prices in other countries? I want to see what the deal is, and until then, you can stop telling us it was all great for the American people, but you just refused to show us the receipts. That’s not how oversight works.
Senator Warren has led efforts to push back against Big Pharma and use every tool available in government to lower drug prices:
- In August 2026, Senator Elizabeth Warren (D-Mass.) slammed Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for his refusal to release the Trump administration’s secret pricing deals with drug companies and for breaking a promise he made to Warren in a recent hearing. Senator Warren also released a new response from Secretary Kennedy that raises doubts about the accuracy of the Trump administration’s claims of cost savings from the secret pharma deals.
- In May 2026, Senators Elizabeth Warren (D-Mass.) and Josh Hawley (R-Mo.), alongside Representatives Diana Harshbarger (R-Tenn.) and Jake Auchincloss (D-Mass.), reintroduced the Patients Before Monopolies (PBM) Act with expanded bipartisan support, indicating growing momentum for a policy that will prohibit joint ownership of pharmacy benefit managers (PBMs) and pharmacies, a gross conflict of interest that enables these companies to enrich themselves at the expense of patients and independent pharmacies.
- In April 2026, Senator Elizabeth Warren pressed Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. on multiple commitments she secured during an exchange in a Senate Finance Committee hearing.
- In April 2026, at a hearing of the Senate Finance Committee, Senator Elizabeth Warren pressed Secretary of the Department of Health and Human Services (HHS) Robert F. Kennedy Jr. on TrumpRx, revealing how President Trump’s marquee drug pricing effort often provides higher prices for Americans while boosting Big Pharma’s bottom line.
- In April 2026, Senator Elizabeth Warren, a member of the Senate Finance Committee; Ron Wyden (D-Ore.), Ranking Member of the Senate Finance Committee; and 18 Senate Democrats introduced new legislation to force the Trump Administration to disclose the terms of deals signed with more than a dozen of the largest pharmaceutical companies and conduct an independent analysis to determine whether American families will see lower prices from the deals.
- In February 2026, Senators Elizabeth Warren and Josh Hawley (R-Mo.) introduced the Break Up Big Medicine Act to address rampant consolidation in the health care industry that drives up prices, squashes competition, and fuels corporate greed.
- In November 2025, Senator Elizabeth Warren, Senate Minority Leader Chuck Schumer (D-N.Y.), and Finance Committee Ranking Member Ron Wyden (D-Ore.) led 25 Senate Democrats in slamming the Trump administration for its failure to address rising health care costs for American families.
- In June 2025, Senator Elizabeth Warren, a member of the Senate Finance Committee, and Representative Jan Schakowsky (D-Ill.) wrote to AbbVie, Pfizer, Amgen, Merck, and Johnson & Johnson, calling them out for taking advantage of tax loopholes created by President Trump’s 2017 tax bill and lobbying for even more tax giveaways.
- In March 2025, Senator Elizabeth Warren, along with Senate Finance Ranking Member Ron Wyden (D-Ore.) and Senate Health, Education, Labor, and Pensions (HELP) Ranking Member Bernie Sanders (I-Vt.), pressed Department of Health and Human Services Secretary Robert F. Kennedy Jr. on his promises to “clean up corruption” and “stop the revolving door between industry and government,” following reports that Kennedy attended multiple “million-dollar” dinners with Big Pharma executives at President Trump’s Mar-a-Lago club.
###